longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Atrium Therapeutics(RNA.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News

StockTitan·05/14/2026 20:40
US
RNA
+2.16%
StockTitan·05/14/2026 20:40
US
RNA
+2.16%

11:44 ETAdvaita Bio představuje iSCanGuide™: Integrovanou analýzu jednobuněčné a prostorové transkriptomiky využívající infrastrukturu s GPU akcelerací

prnewswire·05/08/2026 23:45
US
RNA
+2.16%
US
MBIO
-0.23%
US
SBIO
+0.62%
prnewswire·05/08/2026 23:45
US
RNA
+2.16%
US
MBIO
-0.23%
US
SBIO
+0.62%

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month

benzinga_article·04/21/2026 18:26
US
KNSA
-0.09%
US
NNOX
+4.97%
US
RNA
+2.16%
benzinga_article·04/21/2026 18:26
US
KNSA
-0.09%
US
NNOX
+4.97%
US
RNA
+2.16%

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News

StockTitan·04/21/2026 02:50
US
RNA
+2.16%
StockTitan·04/21/2026 02:50
US
RNA
+2.16%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Atrium Therapeutics released FY2026 Q1 earnings on May 14 (EST), actual revenue USD 19.64 M (forecast USD 2 M), actual EPS USD -0.9723 (forecast USD -1.05)
03:00
Feb24
Atrium Therapeutics released FY2025 earnings on February 23 (EST), actual revenue USD 18.62 M, actual EPS USD -3.1905 (forecast EPS USD -4.4791)
04:00
Atrium Therapeutics released FY2025 Q4 earnings on February 23 (EST), actual revenue USD 859K, actual EPS USD -1.8779
04:00
Feb4
JPMorgan Expresses Concern Over Novartis' Long-Term Prospects
02:09
Dec16
Pharmaceutical Industry M&A Value Up 31% in 2025 to $179.6 Billion
17:43
Nov24
Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement
22:11

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 19.64 M, Net Income -16.63 M, EPS -0.9723

Feb23
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 859 K, Net Income -29.14 M, EPS -1.8779

Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCLA
2.480
+77.14%
+1.090
ATPC
3.490
+66.99%
+1.400
CODX
3.770
+57.74%
+1.400
RGTU
27.800
+52.00%
+9.510
RGTX
27.400
+51.55%
+9.320
QBTX
18.070
+51.34%
+6.060
AKAN
21.500
+48.17%
+6.990
NCPL
0.6685
+47.28%
+0.215
AMPGR
0.8200
+46.43%
+0.260
LIMN
0.2721
+44.89%
+0.084
View More